RBL Bank share price jumped 3.28 percent on Friday. The private banking counter has been trading close to its yearly highs and technical charts suggest strong momentum in the stock.
Glenmark Pharmaceuticals has seized the spotlight within India’s pharmaceutical landscape, propelled by a record-breaking global licensing agreement for its flagship oncology asset.
Divi's Labs and Glenmark shares jumped to 52-week highs and the stocks closed near their highs. On technical charts, both the stocks are looking strong.